Media Coverage · January 5, 2018
Yannick Plétan est nommé directeur médical – Executives [FR]
January 2018. Yannick Plétan est nommé directeur médical, responsable de la R&D clinique et des affaires médicales de cette société de biotechnologie.
Download full text article (PDF, French)
Read next in 'Media Coverage'
- Novel antiplatelet could circumvent bleeding risk for stroke patients
- Experimental antiplatelet compound for acute stroke shows promise
- New drug to prevent clots clears safety hurdle
- New blood thinner may prevent stroke, without risk for bleeding
- Acticor's blood thinner cuts hemorrhage risk in human study, could offer hope for acute stroke